Nicholas Smith's most recent trade in Eagle Financial Services, Inc. was a trade of 303 Common Stock, $2.50 Par Value done at an average price of $33 . Disclosure was reported to the exchange on July 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eagle Financial Services, ... | Nicholas Peter Smith | EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 33.00 per share. | 31 Jul 2025 | 303 | 4,009 | - | 33 | 9,999 | Common Stock, $2.50 Par Value |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 202,329 | 202,329 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jul 2025 | 202,329 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 135,000 | 135,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jul 2025 | 135,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jul 2025 | 90,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 90,000 | 90,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jul 2025 | 44,962 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 44,962 | 44,962 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jul 2025 | 33,833 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 33,833 | 33,833 | - | - | Employee Stock Option (Right to Buy) | |
| Eagle Financial Services, ... | Nicholas Peter Smith | EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.15 per share. | 01 May 2025 | 291 | 3,706 | - | 30.2 | 8,774 | Common Stock, $2.50 Par Value |
| Eagle Financial Services, ... | Nicholas Peter Smith | EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 32.00 per share. | 07 Feb 2025 | 156 | 3,997 | - | 32 | 4,992 | Common Stock, $2.50 Par Value |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 135,000 | 135,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 16.56 per share. | 28 Mar 2024 | 4,550 | 26,866 | - | 16.6 | 75,348 | Common Stock |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 15.80 per share. | 28 Mar 2024 | 1,600 | 22,316 | - | 15.8 | 25,280 | Common Stock |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 90,000 | 90,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 19,153 | 20,716 | - | 0 | Common Stock | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 06 Feb 2024 | 1,563 | 1,563 | - | 16 | 25,008 | Common Stock |
| AG Mortgage Investment Trust | Nicholas Smith | Chief Investment Officer | Other type of transaction at price $ 0.00 per share. | 19 Jul 2021 | 166,666 | 166,666 (0%) | 0% | 0 | Common Stock |